|

Parkinson's Disease Clinical Trials in Orlando, FL

11 recruiting studies within 50 miles

Phase
Trial Phase Dist.
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's DiseasePhase 4<1 mi
A Study of LY4006896 in Healthy Participants and Participants With Parkinson's DiseasePhase 1<1 mi
A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)Phase 2<1 mi
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's DiseasePhase 2<1 mi
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's DiseasePhase 3<1 mi
A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications—<1 mi
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor FluctuationsPhase 2<1 mi
A Study of Buntanetap in Participants With PDPhase 2/35 mi
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's DiseasePhase 2/36 mi
SAD Study in Patients With Parkinson's Disease and Motor FluctuationsPhase 16 mi
Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's DiseasePhase 245 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.